Surface Antigen Markers

Handbook of Stem Cells

Volumn 1, Issue , 2004, Pages 565-571

  Draper, Jonathan S ^a   Andrews, Peter W ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889492263     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012436643-5/50065-1     Document Type: Chapter

References (62)

1. Boyse E.A., Old L.J. Some aspects of normal and abnormal cell surface genetics. Ann. Rev. Genet. 1969, 3:269-290.
2. Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256:495-497.
3. Mason D.Y., Andre P., Bensussan A., Buckley C., Civin C., Clark E., de Haas M., Goyert S., Hadam M., Hart D., Horejsi V., Meuer S., Morissey J., Schwartz-Albiez R., Shaw S., Simmons D., Uguccioni M., van der Schoot E., Viver E., Zola H. CD antigens. Tiss. Antigens 2001, 58:425-430.
4. Weissman I.L., Anderson D.J., Gage F. Stem and progenitor cells: Origins, phenotypes, lineage commitments, and transdifferentiations. Annu. Rev. Cell Dev. Biol. 2001, 17:387-403.
5. Tippett P., Andrews P.W., Knowles B.B., Solter D., Goodfellow P.N. Red cell antigens P (globoside) and Luke: Identification by monoclonal antibodies defining the murine stage-specific embryonic antigens 3 and 4 (SSEA-3 and -4). Vox Sang. 1986, 51:53-56.
6. Artzt K., Dubois P., Bennett D., Condamine H., Babinet C., Jacob F. Surface antigens common to mouse cleavage embryos and primitive teratocarcinoma cells in culture. Proc. Natl. Acad. Sci. USA 1973, 70:2988-2992.
7. Jacob F. Mouse teratocarcinoma and mouse embryo. Proc. R. Soc. Lond. B. 1978, 201:249-270.
8. Martin G.R. Teratocarcinoma and mammalian embryogenesis. Science 1980, 209:768-776.
9. Solter D., Knowles B.B. Monoclonal antibody defining a stage-specific mouse embryonic antigen SSEA1. Proc. Natl. Acad. Sci. USA 1978, 75:5565-5569.
10. Goodfellow P.N., Levinson J.R., Williams V.E., McDevitt H.O. Monoclonal antibodies reacting with murine teratocarcinoma cells. Proc. Natl. Acad. Sci. USA 1979, 76:377-380.
11. Gooi H., Thorpe S.J., Hounsell E.F., Rumpold H., Kraft D., Forster O., Feizi T. Marker of peripheral blood granulocytes and monocytes of man recognized by two monoclonal antibodies VEP8 and VEP9 involves the trisaccharide 3-fucosyl-N-acetyllactosamine. Eur. J. Immunol. 1983, 13:306-312.
12. Kannagi R., Nudelman E., Levery S.B., Hakomori S. A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen, SSEA1. J. Biol. Chem. 1982, 257:14,865-14,874.
13. Andrews P.W., Knowles B.B., Cossu G., Solter D. Teratocarcinoma and mouse embryo cell surface antigens: characterization of the molecules carrying the SSEA1 antigenic determinant. Teratocarcinoma and Embryonic Cell Interactions 1982, 103-119. Japan Scientific Societies Press, Philadelphia. T. Murumatsu (Ed.).
14. Childs R.A., Pennington J., Uemura K., Scudder P., Goodfellow P.N., Evans M.J., Feizi T. High-molecular-weight glycoproteins are the major carriers of the carbohydrate differentiation antigens I, i, and SSEA1 of mouse teratocarcinoma cells. Biochem. J. 1983, 215:491-503.
15. Solter D., Shevinsky L., Knowles B.B., Strickland S. The induction of antigenic changes in a teratocarcinoma stem cell line F9 by retinoic acid. Dev. Biol. 1979, 70:515-521.
16. Buckalew J.J., Sterman B., Rosenstraus M. Variant embryonal carcinoma cells lacking SSEA1 and Forssman antigens remain developmentally pluripotent. Dev. Biol. 1985, 107:134-141.
17. Gregorova S., Loudova M., Dohnal K., Nosek J., Forejt J. Establishment of a pluripotent embryonal carcinoma cell line not expressing SSEA1 and ECMA-7 phenotypes. Cell Differ. 1984, 15:87-92.
18. Rosenstraus M.J. Isolation and characterization of an embryonal carcinoma cell line lacking SSEA1 antigen. Dev. Biol. 1983, 99:318-323.
19. Shevinsky L.H., Knowles B.B., Damjanov I., Solter D. Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human teratocarcinoma cells. Cell 1982, 30:697-705.
20. Kannagi R., Cochran N.A., Ishigami F., Hakomori S.I., Andrews P.W., Knowles B.B., Solter D. Stage-specific embryonic antigens SSEA3 and -4 are epitopes of a unique globoseries ganglioside isolated from human teratocarcinoma cells. EMBO J. 1983, 2:2355-2361.
21. Stern P.L., Willison K.R., Lennox E., Galfre G., Milstein C., Secher D., Ziegler A. Monoclonal antibodies as probes for differentiation and tumor-associated antigens: a Forssman specificity on teratocarcinoma stem cells. Cell 1978, 14:775-783.
22. Willison K.R., Stern P.L. Expression of a Forssman antigenic specificity in the preimplantation mouse embryo. Cell 1978, 14:785-793.
23. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
24. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 1981, 78:7634-7638.
25. Matsui Y., Zsebo K., Hogan B.L. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell 1992, 70:841-847.
26. Labosky P.A., Barlow D.P., Hogan B.L. Mouse embryonic germ (EG) cell lines: transmission through the germ line and differences in the methylation imprint of insulin-like growth factor 2 receptor (Igf2r) gene compared with embryonic stem (ES) cell lines. Development 1994, 120:3197-3204.
27. Hogan B., Fellows M., Avner P., Jacob F. Isolation of a human teratoma cell line, which expresses F9 antigen. Nature 1977, 270:515-518.
28. Holden S., Bernard O., Artzt K., Whitmore W.F., Bennett D. Human and mouse embryonal carcinoma cells in culture share an embryonic antigen F9. Nature 1977, 270:518-520.
29. Andrews P.W., Bronson D.L., Benham F., Strickland S., Knowles B.B. A comparative study of eight cell lines derived from human testicular teratocarcinoma. Int. J. Cancer 1980, 26:269-280.
30. Andrews P.W., Goodfellow P.N., Shevinsky L.H., Bronson D.L., Knowles B.B. Cell-surface antigens of a clonal human embryonal carcinoma cell line: morphological and antigenic differentiation in culture. Int. J. Cancer 1982, 29:523-531.
31. Damjanov I., Fox N., Knowles B.B., Solter D., Lange P.H., Fraley E.E. Immunohistochemical localization of murine stage-specific embryonic antigens in human testicular germ cell tumors. Am. J. Pathol. 1982, 108:225-230.
32. Krupnick J.G., Damjanov I., Damjanov A., Zhu Z.M., Fenderson B.A. Globoseries carbohydrate antigens are expressed in different forms on human and murine teratocarcinoma-derived cells. Int. J. Cancer 1994, 59:692-698.
33. Fenderson B.A., Andrews P.W., Nudelman E., Clausen H., Hakomori S. Glycolipid core structure switching from globo- to lacto- and ganglioseries during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells. Dev. Biol. 1987, 122:21-34.
34. Chen C., Fenderson B.A., Andrews P.W., Hakomori S.I. Glycolipid-glycosyltransferases in human embryonal carcinoma cells during retinoic acid-induced differentiation. Biochemistry 1989, 28:2229-2238.
35. Andrews P.W., Damjanov I., Simon D., Dignazio M. A pluripotent human stem cell clone isolated from the TERA-2 teratocarcinoma line lacks antigens SSEA-3 and SSEA-4 in vitro but expresses these antigens when grown as a xenograft tumor. Differentiation 1985, 29:127-135.
36. Thompson S., Stern P.L., Webb M., Walsh F.S., Engström W., Evans E.P., Shi W.K., Hopkins B., Graham C.F. Cloned human teratoma cells differentiate into neuron-like cells and other cell types in retinoic acid. J. Cell Sci. 1984, 72:37-64.
37. Fenderson B.A., Radin N., Andrews P.W. Differentiation antigens of human germ cell tumors: distribution of carbohydrate epitopes on glycolipids and glycoproteins analyzed using PDMP, an inhibitor of glycolipid synthesis. Eur. Urol. 1993, 23:30-37.
38. Fenderson B.A., Ostrander G.K., Hausken Z., Radin N.S., Hakomori S. A ceramide analogue, PDMP, inhibits glycolipid synthesis in fish embryos. Exp. Cell Res. 1992, 198:362-366.
39. Race R.R., Sanger R. Blood Groups in Man 1975, 169-171. Blackwell Scientific Publications, Tokyo. 6th ed.
40. Andrews P.W., Banting G., Damjanov I., Arnaud D., Avner P. Three monoclonal antibodies defining distinct differentiation antigens associated with different high-molecular-weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma 1984, 3:347-361.
41. Badcock G., Pigott C., Goepel J., Andrews P.W. The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan. Cancer Res. 1999, 59:4715-4719.
42. Pera M.F., Blasco-Lafita M.J., Cooper S., Mason M., Mills J., Monaghan P. Analysis of cell differentiation lineage in human teratomas using new monoclonal antibodies to cytostructural antigens of embryonal carcinoma cells. Differentiation 1988, 39:139-149.
43. Cooper S., Bennett W., Andrade J., Reubinoff B.E., Thomson J., Pera M.F. Biochemical properties of a keratan sulfate-chondroitin sulfate proteoglycan expressed in primate pluripotent stem cells. J. Anat. 2002, 200:259-265.
44. Rettig W.J., Cordon-Cardo C., Ng J.S., Oettgen H.F., Old L.J., Lloyd K.O. High-molecular-weight glycoproteins of human teratocarcinoma defined by monoclonal antibodies to carbohydrate determinants. Cancer Res. 1985, 45:815-821.
45. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
46. Reubinoff B.E., Pera M.F., Fong C.Y., Trounson A., Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 2000, 18:399-404.
47. Draper J.S., Pigott C., Thomson J.A., Andrews P.W. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J. Anat. 2002, 200:249-258.
48. Henderson J.K., Draper J.S., Baillie H.S., Fishel S., Thomson J.A., Moore H., Andrews P.W. Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells 2002, 20:329-337.
49. Andrews P.W., Meyer L.J., Bednarz K.L., Harris H. Two monoclonal antibodies recognizing determinants on human embryonal carcinoma cells react specifically with the liver isozyme of human alkaline phosphatase. Hybridoma 1984, 3:33-39.
50. Andrews P.W., Goodfellow P.N., Bronson D.L. Cell-surface characteristics and other markers of differentiation of human teratocarcinoma cells in culture. Teratocarcinoma Stem Cells 1983, 579-590. Cold Springer Harbor Press, Oxford. Silver (Ed.).
51. Andrews P.W., Damjanov I., Simon D., Banting G., Carlin C., Dracopoli N.C., Fogh J. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2: differentiation in vivo and in vitro. Lab. Invest. 1984, 50:147-162.
52. Andrews P.W. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol. 1984, 103:285-293.
53. Eisenbarth G.S., Walsh F.S., Nirenberg M. Monoclonal antibody to a plasma membrane antigen of neurons. Proc. Natl. Acad. Sci. USA 1979, 76:4913-4917.
54. Andrews P.W., Nudelman E., Hakomori S., Fenderson B.A. Different patterns of glycolipid antigens are expressed following differentiation of TERA-2 human embryonal carcinoma cells induced by retinoic acid, hexamethylene bisacetamide (HMBA), or bromodeoxyuridine (BrdU). Differentiation 1990, 43:131-138.
55. Przyborski S.A., Morton I.E., Wood A., Andrews P.W. Developmental regulation of neurogenesis in the pluripotent human embryonal carcinoma cell line NTERA-2. Eur. J. Neurosci. 2000, 12:3521-3528.
56. Andrews P.W., Bronson D.L., Wiles M.V., Goodfellow P.N. The expression of major histocompatibility antigens by human teratocarcinoma-derived cells lines. Tissue Antigens 1981, 17:493-500.
57. Andrews P.W., Trinchieri G., Perussia B., Baglioni C. Induction of class 1 major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection. Cancer Res. 1987, 47:740-746.
58. Andrews P.W., Casper J., Damjanov I., Duggan-Keen M., Giwercman A., Hata J.I., von Keitz A., Looijenga L.H.J., Millán J.L., Oosterhuis J.W., Pera M., Sawada M., Schmoll H.J., Skakkebaek N.E., van Putten W., Stern P. Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumors. Int. J. Cancer 1996, 66:806-816.
59. Williams B.P., Daniels G.L., Pym B., Sheer D., Povey S., Okubo Y., Andrews P.W., Goodfellow P.N. Biochemical and genetic analysis of the Ok[a] blood group antigen. Immunogenetics 1988, 27:322-329.
60. Thurin J., Herlyn M., Hindsgaul O., Stromberg N., Karlsson K.A., Elder D., Steplewski Z., Koprowski H. Proton NMR and fast-atom bombardment mass spectrometry analysis of the melanoma-associated ganglioside 9-O-acetyl-GD3. J. Biol. Chem. 1985, 260:14,556-14,563.
61. Brodsky F.M., Bodmer W.F., Parham P. Characterization of a monoclonal antiβ 2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens. Eur. J. Immunol. 1979, 9:536-545.
62. Barnstable C.J., Bodmer W.F., Brown G., Galfre G., Milstein C., Williams A.F., Ziegler A. Production of monoclonal antibodies to group A erythrocytes, HLA, and other human cell surface antigens: new tools for genetic analysis. Cell 1978, 14:9-20.